U.S. Health Secretary Robert F. Kennedy Jr.'s recent dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) has triggered a strong backlash from vaccine experts. The ousted panelists warn that the abrupt shakeup may undermine public health, reduce access to lifesaving vaccines, and increase the risk of preventable disease outbreaks.
Kennedy, a longtime vaccine skeptic, replaced the committee with eight new appointees, some of whom have publicly questioned vaccine safety. The decision was made just two days after the firings on June 9, 2025. In a joint article published in the Journal of the American Medical Association (JAMA), the former ACIP members expressed alarm over what they described as a destabilizing and unjustified overhaul.
They argue that the move, along with cuts to CDC immunization staff, weakens the national vaccine program and threatens decades of progress. “These decisions, made without clear rationale, may roll back the achievements of U.S. immunization policy,” the experts wrote. They emphasized the potential risk to public trust and the safety of families across the country.
Kennedy claimed the firings were necessary to eliminate alleged conflicts of interest among the previous panel members, many of whom were appointed during the Biden administration. However, he provided no evidence of specific misconduct or bias.
Health professionals and scientists warn that politicizing vaccine oversight could erode confidence in health authorities and negatively impact vaccine uptake. The Department of Health and Human Services has not yet responded to media inquiries regarding the controversy.
Kennedy’s sweeping changes mark a significant shift in U.S. health policy and come amid growing concerns over misinformation and vaccine hesitancy.


Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Iran Demands Lebanon Be Part of Any Ceasefire Deal With Israel and the U.S.
TSA Absences Surge During Government Shutdown as ICE Agents Prepare Airport Deployment
FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
U.S. Deploys Elite 82nd Airborne Troops to Middle East Amid Iran Tensions
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Microsoft Backs Anthropic in Legal Fight Against Pentagon's AI Blacklist
U.S. Pulls Back Proposed AI Chip Export Rule Amid Policy Uncertainty
X Agrees to Overhaul Blue Checkmark System in EU After €120 Million DSA Fine
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review
Palestinian Activist Leqaa Kordia Released from U.S. Immigration Detention After Judge's Order
Trump Seeks Quick End to U.S.-Iran Conflict Amid Ongoing Middle East Tensions
Israel Eyes Litani River as New Border Amid Escalating Lebanon Offensive 



